Cargando…

Heterozygous Pathogenic and Likely Pathogenic Symptomatic HTRA1 Variant Carriers in Cerebral Small Vessel Disease

High temperature requirement serine peptidase A1 (HTRA1) related cerebral small vessel disease (CSVD) includes both symptomatic heterozygous HTRA1 variant carrier and cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) patients. Presently, most repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Sui-Yi, Li, Hui-Juan, Li, Shun, Ren, Qian-Qian, Liang, Jian-Lin, Li, Chang-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066890/ https://www.ncbi.nlm.nih.gov/pubmed/37016629 http://dx.doi.org/10.2147/IJGM.S404813

Ejemplares similares

Identified novel heterozygous HTRA1 pathogenic variants in Chinese patients with HTRA1-associated dominant cerebral small vessel disease
por: Chen, Mei-Jiao, et al.
Publicado: (2022)

Novel Heterozygous HTRA1 Pathogenic Variant Found in a Chinese Family with Autosomal Dominant Cerebral Small Vessel Disease
por: Wu, Changzhu, et al.
Publicado: (2020)

Cerebral Small Vessel Disease Related to a Heterozygous Nonsense Mutation in HTRA1
por: Ohta, Kentaro, et al.
Publicado: (2020)

Report of two pedigrees with heterozygous HTRA1 variants‐related cerebral small vessel disease and literature review
por: Zhou, Hui, et al.
Publicado: (2022)

Cerebral small vessel disease due to a unique heterozygous HTRA1 mutation in an African man
por: Oluwole, Olusegun John, et al.
Publicado: (2019)

A novel heterozygous HTRA1 mutation is associated with autosomal dominant hereditary cerebral small vessel disease
por: Zhuo, Zhong‐ling, et al.
Publicado: (2020)

Reply to: “Inappropriate interpretation of non‐pathogenic HTRA1 variant as pathogenic”
por: Zhang, Chen, et al.
Publicado: (2023)

CalDAG-GEFI Deficiency in a Family with Symptomatic Heterozygous and Homozygous Carriers of a Likely Pathogenic Variant in RASGRP2
por: Morais, Sara, et al.
Publicado: (2021)

HTRA1-related autosomal dominant cerebral small vessel disease
por: Liu, Jing-Yi, et al.
Publicado: (2021)

Inappropriate interpretation of non‐pathogenic HTRA1 variant as pathogenic
por: Uemura, Masahiro, et al.
Publicado: (2023)

Heterozygous HTRA1 Mutations Cause Cerebral Small Vessel Diseases: Genetic, Clinical, and Pathologic Findings From 3 Chinese Pedigrees
por: Yao, Tingyan, et al.
Publicado: (2022)

Novel mutations in HTRA1 ‐related cerebral small vessel disease and comparison with CADASIL
por: Zhang, Chen, et al.
Publicado: (2022)

Heterozygous HTRA1 missense mutation in CADASIL-like family disease
por: Wu, Xiaowei, et al.
Publicado: (2018)

Severe Cerebral Small Vessel Disease Caused by the Uniallelic p.A252T Variant of HTRA1
por: Kondo, Yasufumi, et al.
Publicado: (2022)

HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature
por: Uemura, Masahiro, et al.
Publicado: (2020)

Autosomal Dominant Cerebral Small Vessel Disease in HTRA1 Gene Mutation
por: Mahale, Rohan R., et al.
Publicado: (2021)

Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects
por: Mishra, Aniket, et al.
Publicado: (2019)

Clinicoradiographic and genetic features of cerebral small vessel disease indicate variability in mode of inheritance for monoallelic HTRA1 variants
por: Muthusamy, Karthik, et al.
Publicado: (2021)

A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1
por: Qian, Emi, et al.
Publicado: (2023)

A novel heterozygous HTRA1 mutation in an Asian family with CADASIL‐like disease
por: Cao, Hua, et al.
Publicado: (2021)

Case report: Heterozygous mutation in HTRA1 causing typical cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy
por: Li, Yu-Ming, et al.
Publicado: (2023)

Cerebral Small Vessel Disease
por: Li, Qian, et al.
Publicado: (2018)

HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade
por: Uemura, Masahiro, et al.
Publicado: (2019)

High frequency of HTRA1 AND ABCC6 mutations in Japanese patients with adult-onset cerebral small vessel disease
por: Uemura, Masahiro, et al.
Publicado: (2023)

MCAD deficiency caused by compound heterozygous pathogenic variants in ACADM
por: Nohara, Fumikatsu, et al.
Publicado: (2022)

Pathogenic variants in HTRA2 cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria
por: Oláhová, Monika, et al.
Publicado: (2016)

Corrigendum: HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade
por: Uemura, Masahiro, et al.
Publicado: (2021)

X Chromosome Inactivation Pattern and Pregnancy Outcome of Female Carriers of Pathogenic Heterozygous X-Linked Deletions
por: Zhao, Yuanyin, et al.
Publicado: (2021)

Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
por: Silva, Rita Santos, et al.
Publicado: (2022)

The CFTR Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS Results
por: Makarova, Maria, et al.
Publicado: (2023)

A novel heterozygous ATP1A2 pathogenic variant in a Chinese child with MELAS‐like alternating hemiplegia
por: Zhang, Xin, et al.
Publicado: (2023)

Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Function of Serine Protease HtrA in the Lifecycle of the Foodborne Pathogen Campylobacter jejuni
por: Boehm, Manja, et al.
Publicado: (2018)

Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review
por: Chen, Weijie, et al.
Publicado: (2022)

Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers
por: Rijken, Johannes A., et al.
Publicado: (2019)

Quantification of serine protease HtrA molecules secreted by the foodborne pathogen Campylobacter jejuni
por: Neddermann, Matthias, et al.
Publicado: (2019)

Compound heterozygous pathogenic variants in the GALC gene cause infant-onset Krabbe disease
por: Zhang, Xiaoli, et al.
Publicado: (2021)

Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
por: Megid, Thais Baccili Cury, et al.
Publicado: (2022)

Exome sequencing identifies novel dysferlin mutation in a family with pauci-symptomatic heterozygous carriers
por: Jalali-Sefid-Dashti, Mahjoubeh, et al.
Publicado: (2018)

Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
por: Yao K, Katharine A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pih2d6aqc2b40c1eh4frrf182